文献速递糖尿病

血清尿调节素预测1型糖尿病成人12年冠状动脉钙化与糖尿病肾病风险较低

Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
PubMed 文献 · Diabetes Care · 2018-11-27

在CACTI研究中,527例1型糖尿病成人(平均年龄39.6岁,糖尿病中位病程24.8年)基线血清尿调节素(SUMOD)每升高1个标准差(68.44 ng/mL),12年随访期间冠状动脉钙化进展、白蛋白排泄升高、快速GFR下降及GFR受损的 odds 均显著降低,且加入SUMOD可改善预测性能。

要点

  • SUMOD可改善传统风险因素模型对CAC进展和DKD的预测性能。

核心结论

  • 在1型糖尿病成人中,基线SUMOD水平较高可预测12年内CAC进展和新发DKD的 odds 较低。

研究设计与样本

  • CACTI研究纳入527例1型糖尿病成人(53%女性),2002-2004年基线检查,平均随访12.1±1.5年。
  • 基线SUMOD在储存血浆样本中检测,CAC用电子束CT测量,CAC进展定义为平方根转换CAC体积变化≥2.5。
  • DKD指标包括ACR、CKD-EPI肌酐公式eGFR,白蛋白排泄升高定义为ACR≥30 mg/g,快速GFR下降定义为>3 mL/min/1.73 m2/年,GFR受损定义为eGFR<60 mL/min/1.73 m2。

主要发现

  • 基线SUMOD每升高1 SD(68.44 ng/mL),CAC进展的OR为0.68(95%CI 0.48-0.97)。
  • 基线SUMOD每升高1 SD,新发白蛋白排泄升高的OR为0.37(95%CI 0.16-0.86)。
  • 基线SUMOD每升高1 SD,快速GFR下降的OR为0.56(95%CI 0.35-0.91)。
  • 基线SUMOD每升高1 SD,GFR受损的OR为0.44(95%CI 0.24-0.83)。
  • 将SUMOD加入传统风险因素模型后,对CAC进展和新发DKD的预测性能显著改善。

关键数值与推荐

  • 白蛋白排泄升高定义为ACR≥30 mg/g。
  • 快速GFR下降定义为>3 mL/min/1.73 m2/年。
  • GFR受损定义为eGFR<60 mL/min/1.73 m2。
  • CAC进展定义为平方根转换CAC体积变化≥2.5。
  • SUMOD每1 SD为68.44 ng/mL。

临床怎么用

  • 在1型糖尿病成人中,可考虑检测基线SUMOD以辅助识别CAC进展和DKD高风险个体。
  • SUMOD可作为传统风险因素之外的补充预测指标,用于风险分层。
  • SUMOD与肾脏保护及抗炎特性相关,但其临床干预价值尚待进一步研究。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Novel biomarkers are needed to better predict coronary artery calcification (CAC), a marker of subclinical atherosclerosis, and diabetic kidney disease (DKD) in type 1 diabetes. We evaluated the associations between serum uromodulin (SUMOD [a biomarker associated with anti-inflammatory and renal protective properties]), CAC progression, and DKD development over 12 years. RESEARCH DESIGN AND METHODS: Participants (n = 527, 53% females) in the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study were examined during 2002-2004, at a mean age of 39.6 ± 9.0 years and a median duration of diabetes of 24.8 years. Urine albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) determined by the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) creatinine equation were measured at baseline and after a mean follow-up period of 12.1 ± 1.5 years. Elevated albumin excretion was defined as ACR ≥30 mg/g, rapid GFR decline (>3 mL/min/1.73 m2/year), and impaired GFR as eGFR <60 mL/min/1.73 m2. SUMOD was measured on stored baseline plasma samples (Meso Scale Discovery). CAC was measured using electron beam computed tomography. CAC progression was defined as a change in the square root-transformed CAC volume of ≥2.5. RESULTS: Higher baseline SUMOD level conferred lower odds of CAC progression (odds ratio 0.68; 95% CI 0.48-0.97), incident elevated albumin excretion (0.37; 0.16-0.86), rapid GFR decline (0.56; 0.35-0.91), and impaired GFR (0.44; 0.24-0.83) per 1 SD increase in SUMOD (68.44 ng/mL) after adjustment for baseline age, sex, systolic blood pressure, LDL cholesterol, and albuminuria/GFR. The addition of SUMOD to models with traditional risk factors also significantly improved the prediction performance for CAC progression and incident DKD. CONCLUSIONS: Higher baseline SUMOD level predicted lower odds of both CAC progression and incident DKD over 12 years in adults with type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bjornstad P, Wiromrat P, Johnson RJ, et al. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study. Diabetes Care. 2018. PMID: 30482755. doi:10.2337/dc18-1527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。